Frontoparietal activation during response inhibition predicts remission to antidepressants in patients with major depression

Biological Psychiatry

Volumn 79, Issue 4, 2016, Pages 274-281

  Gyurak, Anett ^a,b   Patenaude, Brian ^a,b   Korgaonkar, Mayuresh S ^c   Grieve, Stuart M ^c   Williams, Leanne M ^a,b   Etkin, Amit ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cognition; Continuous performance; Executive function; Go NoGo; Major depressive disorder; Remission; Response inhibition; Selective serotonin reuptake inhibitor; Serotonin norepinephrine reuptake inhibitor; Sustained attention; Treatment prediction antidepressant

Indexed keywords

ESCITALOPRAM; SERTRALINE; VENLAFAXINE; ANTIDEPRESSANT AGENT; CITALOPRAM;

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; COGNITION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HAMILTON DEPRESSION RATING SCALE; HUMAN; INFERIOR PARIETAL CORTEX; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MESENCEPHALON; ONSET AGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SELECTIVE ATTENTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WORKING MEMORY; AUSTRALIA; DEPRESSIVE DISORDER, MAJOR; EXECUTIVE FUNCTION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PREFRONTAL CORTEX; PROGNOSIS; PSYCHOLOGICAL RATING SCALE; REGRESSION ANALYSIS; SHORT TERM MEMORY; SINGLE BLIND PROCEDURE; YOUNG ADULT;

ADULT; ANTIDEPRESSIVE AGENTS; AUSTRALIA; CITALOPRAM; COGNITION; DEPRESSIVE DISORDER, MAJOR; EXECUTIVE FUNCTION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; PREFRONTAL CORTEX; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; REMISSION INDUCTION; SERTRALINE; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VENLAFAXINE HYDROCHLORIDE; YOUNG ADULT;

EID: 84955167653     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.02.037     Document Type: Article

References (42)

1. J.P. Hamilton, A. Etkin, D.J. Furman, M.G. Lemus, R.F. Johnson, and I.H. Gotlib Functional neuroimaging of major depressive disorder: a meta-Analysis and new integration of base line activation and neural response data Am J Psychiatry 169 2012 693 703
2. M.S. Korgaonkar, S.M. Grieve, A. Etkin, S.H. Koslow, and L.M. Williams Using standardized fMRI protocols to identify patterns of prefrontal circuit dysregulation that are common and specific to cognitive and emotional tasks in major depressive disorder: first wave results from the iSPOT-D study Neuropsychopharmacology 38 2013 863 871
3. M. Koenigs, and J. Grafman The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex Behav Brain Res 201 2009 239 243
4. Snyder HR (2013): Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-Analysis and review. Psychol Bull 139:81-132.
5. M.A. Rogers, K. Kasai, M. Koji, R. Fukuda, A. Iwanami, K. Nakagome, and et al. Executive and prefrontal dysfunction in unipolar depression: A review of neuropsychological and imaging evidence Neurosci Res 50 2004 1 11
6. I.H. Gotlib, and J. Joormann Cognition and depression: current status and future directions. Annu Rev Clin Psychol 6 2010 285 312
7. Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS (2004): Neuropsychological Assessment, 4th ed. New York: Oxford University Press.
8. E.E. Smith, and J. Jonides Storage and executive processes in the frontal lobes. Science 283 1999 1657 1661
9. D.T. Stuss, and B. Levine Adult clinical neuropsychology: lessons from studies of the frontal lobes. Annu Rev Psychol 53 2002 401 433
10. A. Gyurak, M.S. Goodkind, A. Madan, J.H. Kramer, B.L. Miller, and R.W. Levenson Do tests of executive functioning predict ability to downregulate emotions spontaneously and when instructed to suppress? Cogn Affect Behav Neurosci 9 2009 144 152
11. A. Gyurak, M.S. Goodkind, J.H. Kramer, B.L. Miller, and R.W. Levenson Executive functions and the down-regulation and up-regulation of emotion Cogn Emot 26 2012 103 118
12. S. Channon, J.E. Baker, and M.M. Robertson Working memory in clinical depression: an experimental study Psychol Med 23 1993 87 91
13. M. Doumas, C. Smolders, E. Brunfaut, F. Bouckaert, and R.T.H. Krampe Dual task performance of working memory and postural control in major depressive disorder Neuropsychology 26 2012 110 118
14. B. Gohier, L. Ferracci, S.A. Surguladze, E. Lawrence, W. El Hage, M.Z. Kefi, and et al. Cognitive inhibition and working memory in unipolar depression J Affect Disord 116 2009 100 105
15. G.E. Bruder, J.E. Alvarenga, D. Alschuler, K. Abraham, J.G. Keilp, D.J. Hellerstein, and et al. Neurocognitive predictors of antidepressant clinical response J Affect Disord 166 2014 108 114
16. S.N. McLennan, and J.L. Mathias The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-Analytic review Int J Geriatr Psychiatry 25 2010 933 944
17. P.B. Fitzgerald, A. Srithiran, J. Benitez, Z.Z. Daskalakis, T.J. Oxley, J. Kulkarni, and et al. An fMRI study of prefrontal brain activation during multiple tasks in patients with major depressive disorder Hum Brain Mapp 29 2008 490 501
18. P.-O. Harvey, P. Fossati, J.-B. Pochon, R. Levy, G. Lebastard, S. Lehéricy, and et al. Cognitive control and brain resources in major depression: an fMRI study using the n-back task Neuroimage 26 2005 860 869
19. J.C. Fournier, R.J. DeRubeis, S.D. Hollon, S. Dimidjian, J.D. Amsterdam, R.C. Shelton, and et al. Antidepressant drug effects and depression severity: a patient-level meta-Analysis JAMA 303 2010 47 53
20. K.N. Fountoulakis, and H.-J. Möller Efficacy of antidepressants: A re-Analysis and re-interpretation of the Kirsch data Int J Neuropsychopharmacol 14 2011 405 412
21. M.H. Trivedi, M. Fava, S.R. Wisniewski, M.E. Thase, F. Quitkin, D. Warden, and et al. Medication augmentation after the failure of SSRIs for depression N Engl J Med 354 2006 1243 1252
22. S.A. Langenecker, S.E. Kennedy, L.M. Guidotti, E.M. Briceno, L.S. Own, T. Hooven, and et al. Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder Biol Psychiatry 62 2007 1272 1280
23. L.M. Williams, A.J. Rush, S.H. Koslow, S.R. Wisniewski, N.J. Cooper, C.B. Nemeroff, and et al. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: Rationale and protocol Trials 12 2011 4
24. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, and et al. the Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20 1998 22 33 quiz 34-57
25. M. Hamilton A rating scale for depression J Neurol Neurosurg Psychiatr 23 1960 56 62
26. R.M. Cohen, J.M. Greenberg, and W.W. IsHak Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD JAMA Psychiatry 70 2013 343 350
27. J.D. Henry, and J.R. Crawford The short-form version of the Depression Anxiety Stress Scales (DASS-21): Construct validity and normative data in a large non-clinical sample Br J Clin Psychol 44 2005 227 239
28. World Health Organization Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL) Qual Life Res 2 1993 153 159
29. P.L. Morosini, L. Magliano, L. Brambilla, S. Ugolini, and R. Pioli Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning Acta Psychiatr Scand 101 2000 323 329
30. M.H. Trivedi, A.J. Rush, H.M. Ibrahim, T.J. Carmody, M.M. Biggs, T. Suppes, and et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation Psychol Med 34 2004 73 82
31. S.M. Grieve, M.S. Korgaonkar, S.H. Koslow, E. Gordon, and L.M. Williams Widespread reductions in gray matter volume in depression Neuroimage 3 2013 332 339
32. A. Miyake, N.P. Friedman, M.J. Emerson, A.H. Witzki, A. Howerter, and T.D. Wager The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: A latent variable analysis Cogn Psychol 41 2000 49 100
33. G.R. Samanez-Larkin, and M. D'Esposito Group comparisons: imaging the aging brain Soc Cogn Affect Neurosci 3 2008 290 297
34. S.M. Grieve, M.S. Korgaonkar, A. Etkin, A. Harris, S.H. Koslow, S. Wisniewski, and et al. Brain imaging predictors and the international study to predict optimized treatment for depression: Study protocol for a randomized controlled trial Trials 14 2013 224
35. K.J. Worsley, S. Marrett, P. Neelin, A.C. Vandal, K.J. Friston, and A.C. Evans A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4 1996 58 73
36. N.U.F. Dosenbach, D.A. Fair, F.M. Miezin, A.L. Cohen, K.K. Wenger, R.A.T. Dosenbach, and et al. Distinct brain networks for adaptive and stable task control in humans Proc Natl Acad Sci U S A 104 2007 11073 11078
37. E. Vul, C. Harris, P. Winkielman, and H. Pashler Puzzlingly high correlations in fMRI studies of emotion, personality, and social cognition Perspect Psychol Sci 4 2009 274 290
38. Etkin A, Patenaude B, Song YJC, Usherwood T, Rekshan W, Schatzberg AF, et al. (2014): A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. http://dox.doi.org/10.1038/npp.2014.333.
39. Williams LM, Korgaonkar MS, Song YC, Paton R, Eagles S, Goldstein-Piekarski A, et al. (2015): Amygdala reactivity to emotional faces in the prediction of general and medication-specific responses to antidepressant treatment in the randomized iSPOT-D trial. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. http://dox.doi.org/10.1038/npp.2015.89.
40. A.S. Selya A practical guide to calculating Cohen's f2, a measure of local effect size, from PROC MIXED. Front Quant Psychol Meas 3 2012 111
41. A.R. Aron, T.W. Robbins, and R.A. Poldrack Inhibition and the right inferior frontal cortex Trends Cogn Sci (Regul Ed 8 2004 170 177
42. R.J. Davidson What does the prefrontal cortex "do" in affect: Perspectives on frontal EEG asymmetry research Biol Psychol 67 2004 219 233